| Literature DB >> 20924794 |
Carmen W S Chan, Byoung Wook Choi, Masahiro Jinzaki, Kakuya Kitagawa, I-Chen Tsai, Hwan Seok Yong, Wei Yu.
Abstract
These practice guidelines are recommended by the Asian Society of Cardiovascular Imaging (ASCI), the sole society in Asia designated for cardiovascular imaging, to provide a framework to healthcare providers for suggested essential elements in cardiac magnetic resonance (CMR) examinations of different disease spectra. The guideline is composed of recommendations on the general technique, acquisition of some basic modules, and protocols on stress tests. The protocols for specific diseases are provided in a table format for quick reference to be easily utilized for everyday clinical CMR.Entities:
Mesh:
Year: 2010 PMID: 20924794 PMCID: PMC2996543 DOI: 10.1007/s10554-010-9708-y
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
Fig. 1A road map for major imaging planes of the cardiac magnetic resonance study
A quick reference on the recommended study protocol in specific diseases (optional items are highlighted in blue)
Checklist for adenosine stress myocardial test
| Pre-procedure | Checked |
| I. Check for contraindication for adenosine stress test | |
| 1. Known hypersensitivity to adenosine | |
| 2. Known or suspected bronchoconstrictive or bronchospastic disease | |
| 3. Heart block more than first degree | |
| 4. Significant sinus bradycardia (resting heart rate <45 bpm) | |
| 5. Systemic arterial hypotension (<90 mmHg) or severe arterial hypertension | |
| 6. Recent myocardial infarction within 3 days | |
| II. Obtain informed consent | |
| III. Perform pre-procedure 12 leads ECG and review by doctor in charge | |
| IV. Place two angiocatheters intravenously to each arm: | |
| 1. One IV 20G in antecubital fossa for contrast | |
| 2. One IV 20–22G for adenosine infusion | |
| V. Set up infusion pump for adenosine: | |
| Drugs dosage: adenosine 0.14mg/kg/min | |
| Patient’s body weight (BW) = _________ kg; Adenosine concentration _________mg/ml | |
| 0.140 (mg/kg/min) × BW (kg)/Adenosine concentration (mg/ml) = | |
| Infusion rate _________ (ml/min) =_________ (ml/h) | |
| Total dose of adenosine to be administrated: | |
| 0.14 (mg/kg/min) × BW (kg) × Infusion time (min) = _________ mg | |
| During-procedure | |
| 1. Oxygen 2 l/min per nasal cannula | |
| 2. Set BP cuff to manual mode. Place BP cuff opposite arm as med administration. | |
| 3. Record baseline vital signs- prior to medication administration | |
| 4. Aminophylline 125 mg in 50 ml normal saline IVB over 5–6 min prn chest pain and shortness of breath | |
| 5. Start adenosine infusion at am/pm (time). Continue vital sign monitoring as shown | |
| Post procedure | |
| 1. Perform post stress ECG and review | |
| 2. Record final vital signs prior to discharge. Report any patient complaints to doctor in charge |
Patient monitoring during adenosine stress cardiac MR examination
Checklist for dobutamine stress myocardial test
| Pre-procedure | Checked |
| I. Check for contraindication for dobutamine stress test | |
| 1. Severe systemic arterial hypertension (≥220/120 mmHg) | |
| 2. Unstable angina | |
| 3. High grade aortic stenosis (aortic valve area <1 cm/peak aortic valve gradient >50 mmHg) | |
| 4. Uncontrolled or complex cardiac arrhythmias | |
| 5. Haemodynamically significant hypertrophic obstructive cardiomyopathy | |
| 6. Uncontrolled heart failure | |
| 7. Myocarditis, endocarditis and pericarditis | |
| 8. History of sudden death | |
| 9. Aortic dissection/high grade aortic aneurysm | |
| 10. Mobile left ventricular or left atrial thrombus | |
| II. Check list for contraindications for atropine | |
| 1. Advance heart block | |
| 2. Glaucoma | |
| 3. Pyloric stenosis | |
| 4. Obstructive uropathy | |
| 5. Myasthenia gravis | |
| II. Obtain informed consent | |
| III. Perform pre-procedure 12 leads ECG and review by doctor in charge | |
| IV. Place two angiocatheters intravenously to each arm: | |
| 1. One IV 20G in antecubital fossa for contrast | |
| 2. One IV 20–22G for adenosine infusion | |
| V. Set up infusion pump for dobutamine infusion: | |
| VI. Additional medication to be ready for use in examination room | |
| 1. TNG table | |
| 2. Metropolol 5 mg/ml | |
| 3. Atropine 0.6 ml × 3 ampules | |
| 4. NS flush | |
| During-procedure | |
| 1. Oxygen 2 l per nasal cannula | |
| 2. Set BP cuff to manual mode. Place BP cuff opposite arm as med administration. | |
| 3. Record baseline vital signs- prior to medication administration | |
| 4. Record time at the start of dobutmaine infusion. Continue vital sign monitoring whenever change of dosage and prn | |
| Post procedure | |
| 1. Perform post stress ECG and review | |
| 2. Record total amount of drugs given | |
| 3. Record final vital signs prior to discharge. Report any patient complaints to doctor in charge |
Patient monitoring during dobutamine stress cardiac MR examination
Adenosine infusion protocol (0.14 mg/kg/min over 6 min) adenosine concentration: 3 mg/ml
| Wt (kg) | Wt (lbs) | Adenosine (mg/min) | Adenosine (ml/h) | Adenosine total dose | Wt (kg) | Wt (lbs) | Adenosine (mg/min) | Adenosine (ml/h) | Adenosine total dose |
|---|---|---|---|---|---|---|---|---|---|
| 40 | 88 | 5.6 | 112 | 34 | 75 | 165 | 10.5 | 210 | 63 |
| 41 | 90 | 5.7 | 114 | 34 | 76 | 167 | 10.6 | 213 | 64 |
| 42 | 92 | 5.9 | 118 | 35 | 77 | 169 | 10.8 | 216 | 65 |
| 43 | 95 | 6.0 | 120 | 36 | 78 | 172 | 10.9 | 218 | 66 |
| 44 | 97 | 6.1 | 122 | 37 | 79 | 174 | 11.1 | 221 | 66 |
| 45 | 99 | 6.3 | 126 | 38 | 80 | 176 | 11.2 | 224 | 67 |
| 46 | 101 | 6.4 | 129 | 39 | 81 | 178 | 11.3 | 227 | 68 |
| 47 | 103 | 6.6 | 132 | 39 | 82 | 180 | 11.5 | 230 | 69 |
| 48 | 106 | 6.7 | 134 | 40 | 83 | 183 | 11.6 | 232 | 70 |
| 49 | 108 | 6.9 | 137 | 41 | 84 | 185 | 11.8 | 235 | 71 |
| 50 | 110 | 7.0 | 140 | 42 | 85 | 187 | 11.9 | 238 | 71 |
| 51 | 112 | 7.1 | 143 | 43 | 86 | 189 | 12.0 | 241 | 72 |
| 52 | 114 | 7.3 | 146 | 44 | 87 | 191 | 12.2 | 244 | 73 |
| 53 | 117 | 7.4 | 148 | 45 | 88 | 194 | 12.3 | 246 | 74 |
| 54 | 119 | 7.6 | 151 | 45 | 89 | 196 | 12.5 | 249 | 75 |
| 55 | 121 | 7.7 | 154 | 46 | 90 | 198 | 12.6 | 252 | 76 |
| 56 | 123 | 7.8 | 157 | 47 | 91 | 200 | 12.7 | 255 | 76 |
| 57 | 125 | 8.0 | 160 | 48 | 92 | 202 | 12.9 | 258 | 77 |
| 58 | 128 | 8.1 | 162 | 49 | 93 | 205 | 13.0 | 260 | 78 |
| 59 | 130 | 8.3 | 165 | 50 | 94 | 207 | 13.2 | 263 | 79 |
| 60 | 132 | 8.4 | 168 | 50 | 95 | 209 | 13.3 | 266 | 80 |
| 61 | 134 | 8.5 | 171 | 51 | 96 | 211 | 13.4 | 269 | 81 |
| 62 | 136 | 8.7 | 174 | 52 | 97 | 213 | 13.6 | 272 | 81 |
| 63 | 139 | 8.8 | 176 | 53 | 98 | 216 | 13.7 | 274 | 82 |
| 64 | 141 | 9.0 | 179 | 54 | 99 | 218 | 13.9 | 277 | 83 |
| 65 | 143 | 9.1 | 182 | 55 | 100 | 220 | 14.0 | 280 | 84 |
| 66 | 145 | 9.2 | 185 | 55 | 101 | 222 | 14.1 | 283 | 85 |
| 67 | 147 | 9.4 | 188 | 56 | 102 | 224 | 14.3 | 286 | 86 |
| 68 | 150 | 9.5 | 190 | 57 | 103 | 227 | 14.4 | 288 | 87 |
| 69 | 152 | 9.7 | 193 | 58 | 104 | 229 | 14.6 | 291 | 87 |
| 70 | 154 | 9.8 | 196 | 59 | 105 | 231 | 14.7 | 294 | 88 |
| 71 | 156 | 19.9 | 199 | 60 | 106 | 233 | 14.8 | 297 | 89 |
| 72 | 158 | 10.1 | 202 | 60 | 107 | 235 | 15.0 | 300 | 90 |
| 73 | 161 | 10.2 | 204 | 61 | 108 | 238 | 15.1 | 302 | 91 |
| 74 | 163 | 10.4 | 207 | 62 | 109 | 240 | 15.3 | 305 | 92 |
Adenosine infusion protocol (0.14 mg/kg/min over 6 min) adenosine concentration: 2 mg/ml
| Wt (kg) | Wt (lbs) | Adenosine (mg/min) | Adenosine (ml/h) | Adenosine total dose | Wt (kg) | Wt (lbs) | Adenosine (mg/min) | Adenosine (ml/h) | Adenosine total dose |
|---|---|---|---|---|---|---|---|---|---|
| 40 | 88 | 5.6 | 168 | 34 | 75 | 165 | 10.5 | 315 | 63 |
| 41 | 90 | 5.7 | 171 | 34 | 76 | 167 | 10.6 | 318 | 64 |
| 42 | 92 | 5.9 | 177 | 35 | 77 | 169 | 10.8 | 324 | 65 |
| 43 | 95 | 6.0 | 180 | 36 | 78 | 172 | 10.9 | 327 | 66 |
| 44 | 97 | 6.1 | 183 | 37 | 79 | 174 | 11.1 | 333 | 66 |
| 45 | 99 | 6.3 | 189 | 38 | 80 | 176 | 11.2 | 336 | 67 |
| 46 | 101 | 6.4 | 192 | 39 | 81 | 178 | 11.3 | 339 | 68 |
| 47 | 103 | 6.6 | 198 | 39 | 82 | 180 | 11.5 | 345 | 69 |
| 48 | 106 | 6.7 | 201 | 40 | 83 | 183 | 11.6 | 348 | 70 |
| 49 | 108 | 6.9 | 207 | 41 | 84 | 185 | 11.8 | 354 | 71 |
| 50 | 110 | 7.0 | 210 | 42 | 85 | 187 | 11.9 | 357 | 71 |
| 51 | 112 | 7.1 | 213 | 43 | 86 | 189 | 12.0 | 360 | 72 |
| 52 | 114 | 7.3 | 219 | 44 | 87 | 191 | 12.2 | 366 | 73 |
| 53 | 117 | 7.4 | 222 | 45 | 88 | 194 | 12.3 | 369 | 74 |
| 54 | 119 | 7.6 | 228 | 45 | 89 | 196 | 12.5 | 375 | 75 |
| 55 | 121 | 7.7 | 231 | 46 | 90 | 198 | 12.6 | 378 | 76 |
| 56 | 123 | 7.8 | 234 | 47 | 91 | 200 | 12.7 | 381 | 76 |
| 57 | 125 | 8.0 | 240 | 48 | 92 | 202 | 12.9 | 387 | 77 |
| 58 | 128 | 8.1 | 243 | 49 | 93 | 205 | 13.0 | 390 | 78 |
| 59 | 130 | 8.3 | 249 | 50 | 94 | 207 | 13.2 | 396 | 79 |
| 60 | 132 | 8.4 | 252 | 50 | 95 | 209 | 13.3 | 399 | 80 |
| 61 | 134 | 8.5 | 255 | 51 | 96 | 211 | 13.4 | 402 | 81 |
| 62 | 136 | 8.7 | 261 | 52 | 97 | 213 | 13.6 | 408 | 81 |
| 63 | 139 | 8.8 | 264 | 53 | 98 | 216 | 13.7 | 411 | 82 |
| 64 | 141 | 9.0 | 270 | 54 | 99 | 218 | 13.9 | 417 | 83 |
| 65 | 143 | 9.1 | 273 | 55 | 100 | 220 | 14.0 | 420 | 84 |
| 66 | 145 | 9.2 | 276 | 55 | 101 | 222 | 14.1 | 423 | 85 |
| 67 | 147 | 9.4 | 282 | 56 | 102 | 224 | 14.3 | 429 | 86 |
| 68 | 150 | 9.5 | 285 | 57 | 103 | 227 | 14.4 | 432 | 87 |
| 69 | 152 | 9.7 | 291 | 58 | 104 | 229 | 14.6 | 438 | 87 |
| 70 | 154 | 9.8 | 294 | 59 | 105 | 231 | 14.7 | 441 | 88 |
| 71 | 156 | 19.9 | 597 | 60 | 106 | 233 | 14.8 | 444 | 89 |
| 72 | 158 | 10.1 | 303 | 60 | 107 | 235 | 15.0 | 450 | 90 |
| 73 | 161 | 10.2 | 306 | 61 | 108 | 238 | 15.1 | 453 | 91 |
| 74 | 163 | 10.4 | 312 | 62 | 109 | 240 | 15.3 | 459 | 92 |